Gates Capital Management, Inc.
Source: SEC Form 13F · as of Mar 2026Gates Capital Management, Inc. holds 2 biotech & pharma companies tracked by BioSniper, totaling $169.3M in value as of Mar 2026 (SEC Form 13F).
Companies held
2
Total value held
$169.3M
BioSniper AIPage evidence connected
Prepared research question
What matters most for DaVita Inc. (DVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| DVADaVita Inc. | 723,008 | $111.1M |
| NEOGNEOGEN CORP | 6,258,649 | $58.1M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.